Sac-TMT/Pembrolizumab Elicits Antitumor Activity in Recurrent Cervical Cancer

Press/Media: Research

Period	Apr 15 2026

Media coverage

Title	Sac-TMT/Pembrolizumab Elicits Antitumor Activity in Recurrent Cervical Cancer
Media name/outlet	Cancernetwork.com
Country/Territory	United States
Date	4/15/26
URL	ct.moreover.com/?a=59329548138&p=1gw&v=1&x=Y1wVm59bj-g4W6UkxGgtRQ
Persons	Xiaoming Wang